Computational simulation of interactions between SARS coronavirus spike mutants and host species-specific receptors

DOI10.1016/J.COMPBIOLCHEM.2007.02.006MaRDI QIDQ2373313zbMATH OpenOpenAlexWikidataFDO

Authors Yuan Zhang, Nan Zheng, Peng Nan, Ying Cao, Masami Hasegawa, Yang Zhong

Publication date 17 July 2007

Published in Computational Biology and Chemistry (Search for Journal in Brave)

Full work available at URL http://europepmc.org/articles/pmc7106403

zbMATH Keywords

ACE2Receptor-binding specificitySpike proteinStructural bioinformatics

Mathematics Subject Classification ID

Computational methods for problems pertaining to biology (92-08) Biochemistry, molecular biology (92C40) Medical applications (general) (92C50)

Recommendations

• Computational characterization and design of SARS coronavirus receptor recognition and antibody neutralization
• A molecular docking model of SARS-CoV S1 protein in complex with its receptor, human ACE2
• Design of an engineered ACE2 as a novel therapeutics against COVID-19
• Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CL\(^{\mathrm{pro}}\) inhibitors
• Particular symmetry in RNA sequence of SARS and the origin of SARS coronavirus

Cited in

(8)

• Particular symmetry in RNA sequence of SARS and the origin of SARS coronavirus
• Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CL\(^{\mathrm{pro}}\) inhibitors
• Computational modeling of protein conformational changes -- application to the opening SARS-CoV-2 spike
• Computational characterization and design of SARS coronavirus receptor recognition and antibody neutralization
• A molecular docking model of SARS-CoV S1 protein in complex with its receptor, human ACE2
• Functional and structural characterization of Ebola virus glycoprotein (1976–2015) — Anin silicostudy
• Modelling how increased Cathepsin B/L and decreased TMPRSS2 usage for cell entry by the SARS-CoV-2 Omicron variant may affect the efficacy and synergy of TMPRSS2 and Cathepsin B/L inhibitors
• Design of an engineered ACE2 as a novel therapeutics against COVID-19

Describes a project that uses

Uses Software

• FoldX

This page was built for publication: Computational simulation of interactions between SARS coronavirus spike mutants and host species-specific receptors

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2373313)